Biomarkers · Vitamins & Endocrine
Thyroid-Stimulating Hormone (TSH)
U-shaped: both low and high values carry risk. Not measured in our NHANES panel; the curve is synthesised from the published association.
Hazard ratio relative to the curve's reference value, as synthesised from the published association.
Published hazard ratio1.45top vs bottom quarter (95% CI 1.12–1.87) · NHANES III Follow-up
Where people sit
Population percentiles (mIU/L) by sex and age band. Cycle or source as recorded in the catalogue.
| Sex | Age | 5th | 25th | Median | 75th | 95th | n | Cycle / source |
|---|---|---|---|---|---|---|---|---|
| All | 20-39 | 0.40 | 1.30 | 1.90 | 2.70 | 4.80 | 2,580 | 2017-2018 |
| All | 40-59 | 0.40 | 1.40 | 2.10 | 3.00 | 5.50 | 2,550 | 2017-2018 |
| All | 60+ | 0.50 | 1.50 | 2.30 | 3.20 | 6.00 | 2,670 | 2017-2018 |
| All | all | 0.40 | 1.40 | 2.10 | 3.00 | 5.50 | 7,800 | 2017-2018 |
| Men | all | 0.40 | 1.30 | 2.00 | 2.90 | 5.20 | 3,780 | 2017-2018 |
| Women | all | 0.40 | 1.50 | 2.20 | 3.10 | 5.80 | 4,020 | 2017-2018 |
Sources
- Hazard curve: Recalculated from mortality_association (HR=1.45 quartile_extreme); per-SD log(HR)=0.2899.
- Thyroid Hormones and Electrocardiographic Parameters: Findings from the Third National Health and Nutrition Examination Survey
Map Thyroid-Stimulating Hormone (TSH) against another biomarker.